PMID- 30815556
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20231005
IS  - 2398-9238 (Electronic)
IS  - 2398-9238 (Linking)
VI  - 1
IP  - 3
DP  - 2018 Jul
TI  - Nudging people with Type 2 diabetes towards better self-management through 
      personalized risk communication: A pilot randomized controlled trial in primary 
      care.
PG  - e00022
LID - 10.1002/edm2.22 [doi]
LID - e00022
AB  - OBJECTIVES: To assess the feasibility in routine primary care consultation and 
      investigate the effect on risk recall and self-management of a new type of risk 
      communication intervention based on behavioural economics ("nudge-based") for 
      people with Type 2 diabetes mellitus (T2DM). METHODS: Forty adults with poorly 
      controlled T2DM (HbA1c > 7.5%) were randomized to receive a personalized, 
      nudge-based risk communication intervention (n = 20) or standard care (n = 20). 
      Risk recall and self-management were evaluated at baseline and 12 weeks after the 
      intervention. RESULTS: Both in terms of feasibility and acceptability, this new 
      risk communication intervention was very satisfactory. Study retention rate after 
      12 weeks was very high (90%) and participants were highly satisfied with the 
      intervention (4.4 out of 5 on the COMRADE scale). Although not powered to 
      identify significant between-group effects, the intervention significantly 
      improved risk recall after 12 weeks and intentions to make lifestyle changes 
      (dietary behaviour) compared to standard care. CONCLUSIONS: This pilot study 
      provides the first evidence of the feasibility of implementing in primary care a 
      nudge-based risk communication intervention for people with T2DM. Based on the 
      promising results observed, an adequately powered trial to determine the 
      effectiveness of the intervention on long-term self-management is judged 
      feasible. As a result of this feasibility study, some minor adaptations to the 
      intervention and study methods that would help to facilitate a definitive trial 
      are also reported.
FAU - Rouyard, Thomas
AU  - Rouyard T
AUID- ORCID: 0000-0001-6412-1360
AD  - Health Economics Research Centre Nuffield Department of Population Health 
      University of Oxford Oxford UK.
FAU - Leal, Jose
AU  - Leal J
AD  - Health Economics Research Centre Nuffield Department of Population Health 
      University of Oxford Oxford UK.
FAU - Baskerville, Richard
AU  - Baskerville R
AD  - Nuffield Department of Primary Care Health Sciences University of Oxford Oxford 
      UK.
FAU - Velardo, Carmelo
AU  - Velardo C
AD  - Institute of Biomedical Engineering Department of Engineering Science University 
      of Oxford Oxford UK.
FAU - Salvi, Dario
AU  - Salvi D
AD  - Institute of Biomedical Engineering Department of Engineering Science University 
      of Oxford Oxford UK.
FAU - Gray, Alastair
AU  - Gray A
AD  - Health Economics Research Centre Nuffield Department of Population Health 
      University of Oxford Oxford UK.
LA  - eng
GR  - NIHR-IPF-2013-07-01/DH_/Department of Health/United Kingdom
PT  - Journal Article
DEP - 20180622
PL  - England
TA  - Endocrinol Diabetes Metab
JT  - Endocrinology, diabetes & metabolism
JID - 101732442
PMC - PMC6354823
OTO - NOTNLM
OT  - Type 2 diabetes
OT  - behavioural economics
OT  - pilot randomized trial
OT  - primary care
OT  - risk communication
OT  - self-management
EDAT- 2019/03/01 06:00
MHDA- 2019/03/01 06:01
PMCR- 2018/06/22
CRDT- 2019/03/01 06:00
PHST- 2018/04/24 00:00 [received]
PHST- 2018/06/01 00:00 [accepted]
PHST- 2019/03/01 06:00 [entrez]
PHST- 2019/03/01 06:00 [pubmed]
PHST- 2019/03/01 06:01 [medline]
PHST- 2018/06/22 00:00 [pmc-release]
AID - EDM222 [pii]
AID - 10.1002/edm2.22 [doi]
PST - epublish
SO  - Endocrinol Diabetes Metab. 2018 Jun 22;1(3):e00022. doi: 10.1002/edm2.22. 
      eCollection 2018 Jul.